These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Statin Use in Older Adults for Primary Cardiovascular Disease Prevention Across a Spectrum of Cardiovascular Risk. Sarraju A, Spencer-Bonilla G, Chung S, Gomez S, Li J, Heidenreich P, Palaniappan L, Rodriguez F. J Gen Intern Med; 2022 Aug; 37(11):2642-2649. PubMed ID: 34505981 [Abstract] [Full Text] [Related]
3. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease. Rodriguez F, Maron DJ, Knowles JW, Virani SS, Lin S, Heidenreich PA. JAMA Cardiol; 2017 Jan 01; 2(1):47-54. PubMed ID: 27829091 [Abstract] [Full Text] [Related]
4. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016. Yao X, Shah ND, Gersh BJ, Lopez-Jimenez F, Noseworthy PA. JAMA Netw Open; 2020 Nov 02; 3(11):e2025505. PubMed ID: 33216139 [Abstract] [Full Text] [Related]
6. Impact of the 2013 Cholesterol Guideline on Patterns of Lipid-Lowering Treatment in Patients with Atherosclerotic Cardiovascular Disease or Diabetes After 1 Year. Tran JN, Kao TC, Caglar T, Stockl KM, Spertus JA, Lew HC, Solow BK, Chan PS. J Manag Care Spec Pharm; 2016 Aug 02; 22(8):901-8. PubMed ID: 27459652 [Abstract] [Full Text] [Related]
11. Retrospective examination of lipid-lowering treatment patterns in a real-world high-risk cohort in the UK in 2014: comparison with the National Institute for Health and Care Excellence (NICE) 2014 lipid modification guidelines. Steen DL, Khan I, Ansell D, Sanchez RJ, Ray KK. BMJ Open; 2017 Feb 17; 7(2):e013255. PubMed ID: 28213597 [Abstract] [Full Text] [Related]
12. Contemporary use of lipid-lowering therapy for secondary prevention in Korean patients with atherosclerotic cardiovascular diseases. Choi SY, Yang BR, Kang HJ, Park KS, Kim HS. Korean J Intern Med; 2020 May 17; 35(3):593-604. PubMed ID: 31752475 [Abstract] [Full Text] [Related]
13. Gaps in Guideline-Based Lipid-Lowering Therapy for Secondary Prevention in the United States: A Retrospective Cohort Study of 322 153 Patients. Navar AM, Kolkailah AA, Gupta A, Gillard KK, Israel MK, Wang Y, Peterson ED. Circ Cardiovasc Qual Outcomes; 2023 Aug 17; 16(8):533-543. PubMed ID: 37529931 [Abstract] [Full Text] [Related]
16. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease. Erqou S, Papaila A, Halladay C, Ge A, Liu MA, Jiang L, Lally M, Menon A, Shah NR, Miech E, Virani SS, Zullo AR, Shireman TI, Longenecker CT, Ross D, Sullivan JL, Wu WC, Rudolph JL. Am Heart J; 2022 Jul 17; 249():12-22. PubMed ID: 35318028 [Abstract] [Full Text] [Related]
20. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan. Olufade T, Zhou S, Anzalone D, Kern DM, Tunceli O, Cziraky MJ, Willey VJ. J Am Heart Assoc; 2017 May 04; 6(5):. PubMed ID: 28473405 [Abstract] [Full Text] [Related] Page: [Next] [New Search]